Under Bryan’s leadership Trinet grew into a world-class firm dedicated exclusively to the pharmaceutical, biotech, device, and diagnostic industries. Trinet enjoyed year-over-year exponential growth and a reputation for excellence that remains today. Following his death, Terry Mulloy became CEO, and now Mara Vaughan joins the leadership team as President.
TriNet is honored to memorialize and celebrate the life of its founder and visionary. Today, the company still embodies the values and vision he began. Mara and all of the employees of TriNet Pharma are proud to lead the company into the future.
TriNet has established a legacy grant in Bryan’s name to pay tribute to his entrepreneurial spirit and his dedication to being a leader in the life sciences industry. Just as the medical affairs space is adapting and changing to meet the needs of the industry, yearly Mara, in her husband’s honor, will determine the best place to award the grant.